DCM
CCXI

Dupont Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Dupont Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,720
Closed -$424K – 1407
2019
Q4 		$424K Buy
+10,720
New +$188K 0.01% 917

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Dupont Capital Management's CCXI Position: Q1 2020 in Review

Dupont Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q1 2020, closing a stake of 10,720 shares — an estimated $424K sold.

Dupont Capital Management first reported a position in CCXI in Q4 2019 and held it in 1 quarter. The position peaked at $424K in Q4 2019. 162 funds tracked by Wall St. Rank hold CCXI as of Q1 2020.

  • Dupont Capital Management reported no remaining ChemoCentryx, Inc. position as of Q1 2020 after selling out during the quarter.
  • Dupont Capital Management sold 10,720 ChemoCentryx, Inc. shares in Q1 2020, an estimated $424K.
  • Dupont Capital Management first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 1 quarter.
  • Dupont Capital Management's ChemoCentryx, Inc. position peaked at $424K in Q4 2019.
  • 162 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2020.

Based on Dupont Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.